EP 1865778 A4 20101208 - METHODS FOR AVOIDING EDEMA IN THE TREATMENT OF METABOLIC, INFLAMMATORY, AND CARDIOVASCULAR DISORDERS
Title (en)
METHODS FOR AVOIDING EDEMA IN THE TREATMENT OF METABOLIC, INFLAMMATORY, AND CARDIOVASCULAR DISORDERS
Title (de)
VERFAHREN ZUR VERMEIDUNG VON ÖDEM BEI DER BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN, ENTZÜNDLICHEN ERKRANKUNGEN UND HERZ-KREISLAUF-ERKRANKUNGEN
Title (fr)
METHODES EMPECHANT LA FORMATION D'OEDEME DANS LE TRAITEMENT DE TROUBLES METABOLIQUES, INFLAMMATOIRES ET CARDIO-VASCULAIRES
Publication
Application
Priority
- US 2006010430 W 20060321
- US 66397705 P 20050321
- US 66451505 P 20050322
Abstract (en)
[origin: WO2006102375A2] Compounds, compositions, and methods of avoiding edema while treating or preventing PPAR?-mediated diseases, including cancer, using derivatives and prodrugs are provided.
IPC 8 full level
A61K 31/185 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 9/20 (2006.01); A61K 31/428 (2006.01); A61K 31/5377 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 9/10 (2006.01); A61P 17/06 (2006.01); A61P 17/10 (2006.01); A61P 19/10 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/428 (2013.01 - EP US); A61K 31/5377 (2013.01 - EP US); A61P 1/04 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 1/18 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 17/10 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
- [XY] WO 2004014308 A2 20040219 - BETHESDA PHARMACEUTICALS INC [US], et al
- [XY] US 2004077659 A1 20040422 - OLIVER JR WILLIAM ROLAND [US]
- [XY] US 2003220399 A1 20031127 - LUSKEY KENNETH L [US], et al
- [XDY] WO 0074666 A2 20001214 - METS OLEX INC [US], et al
- [XY] US 4072754 A 19780207 - SCHACHT ERICH, et al
- [XY] WO 03080545 A2 20031002 - METABOLEX INC [US], et al
- [A] WO 02064094 A2 20020822 - MERCK & CO INC [US], et al
- [A] US 2003220381 A1 20031127 - BIGGE CHRISTOPHER F [US], et al
- [XY] DATABASE WPI Week 200504, Derwent World Patents Index; AN 2005-039725, XP002601823
- [A] TAYLOR B K ET AL: "PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS INHIBIT INFLAMMATORY EDEMA AND HYPERALGESIA", INFLAMMATION, PLENUM PRESS, NEW YORK, NY, US LNKD- DOI:10.1023/A:1015500531113, vol. 26, no. 3, 1 January 2002 (2002-01-01), pages 121 - 127, XP008076909, ISSN: 0360-3997
- See references of WO 2006102426A2
Citation (examination)
HUCKER H B ET AL: "Metabolism of a new hypolipidemic agent, 2-acetamidoethyl .alpha.-(p-chlorophenyl)-.alpha.-(m-trifluoromethylphenoxy)acetate (halofenate) in the rat, dog, rhesus monkey, and man", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, US, vol. 179, no. 2, 1 January 1971 (1971-01-01), pages 359 - 371, XP009157249, ISSN: 0022-3565
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK YU
DOCDB simple family (publication)
WO 2006102375 A2 20060928; WO 2006102375 A3 20090402; EP 1865778 A2 20071219; EP 1865778 A4 20101208; EP 1865954 A2 20071219; EP 1865954 A4 20101215; JP 2008533206 A 20080821; JP 2008538351 A 20081023; US 2008194646 A1 20080814; US 2008269189 A1 20081030; US 8288438 B2 20121016; WO 2006102426 A2 20060928; WO 2006102426 A3 20070503
DOCDB simple family (application)
US 2006010331 W 20060321; EP 06739211 A 20060321; EP 06739286 A 20060321; JP 2008503112 A 20060321; JP 2008503135 A 20060321; US 2006010430 W 20060321; US 90895206 A 20060321; US 90895406 A 20060321